Her primary scientific interests are in Molecular biology, Antibody, Antigen, Immune system and Virology. Her study in Molecular biology is interdisciplinary in nature, drawing from both Peptide sequence, COS cells, B cell and Binding site. Her research combines Blot and Antibody.
She has included themes like Cancer cell, Cancer, Cancer research and Fusion protein in her Immune system study. Her work carried out in the field of Virology brings together such families of science as Epitope, Plasmodium and Hepatocyte. She focuses mostly in the field of Glycoprotein, narrowing it down to topics relating to CD81 and, in certain cases, Transmembrane protein, Tetraspanin, Infectivity, Vacuole and Plasmodium yoelii.
Her main research concerns Molecular biology, Antibody, Immunology, Cell biology and CD81. Shoshana Levy has researched Molecular biology in several fields, including B cell, Biochemistry, Gene and Antigen. Her Antibody research is multidisciplinary, incorporating perspectives in B-cell lymphoma and Virology.
Her research investigates the connection with Immunology and areas like Cytotoxic T cell which intersect with concerns in T cell. Her Cell biology research incorporates elements of Tetraspanin and Cell growth. Her work investigates the relationship between CD81 and topics such as Glycoprotein that intersect with problems in Binding site.
Shoshana Levy mainly focuses on CD81, Tetraspanin, Cancer research, Immunology and Metastasis. She combines subjects such as Molecular biology and Antibody, Monoclonal antibody, B cell with her study of CD81. Her Molecular biology study integrates concerns from other disciplines, such as Budding, Reverse transcriptase, SAMHD1, Immunoglobulin light chain and Viral replication.
Her Tetraspanin study which covers Cell biology that intersects with CD19. Her work in Immunology addresses subjects such as Cytotoxic T cell, which are connected to disciplines such as Pathogen, Immunity and Microbiology. Within one scientific family, Shoshana Levy focuses on topics pertaining to Immune system under Metastasis, and may sometimes address concerns connected to Cancer cell.
Shoshana Levy focuses on Tetraspanin, CD81, Cancer research, Immune system and Immunology. In her study, Mutation, B cell, Signal transduction, CD19 and Cell biology is inextricably linked to Acquired immune system, which falls within the broad field of Tetraspanin. Her CD81 research incorporates themes from Budding, Reverse transcriptase, SAMHD1, Molecular biology and Viral replication.
Her Immunology study frequently draws connections between adjacent fields such as Virology. Her study looks at the relationship between Immunotherapy and fields such as Cancer cell, as well as how they intersect with chemical problems. Her Antibody study combines topics from a wide range of disciplines, such as Virus, Hepacivirus and Lymphoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The tetraspanin superfamily: molecular facilitators.
Holden T. Maecker;Scott C. Todd;Shoshana Levy.
The FASEB Journal (1997)
The tetraspanin web modulates immune-signalling complexes.
Shoshana Levy;Tsipi Shoham.
Nature Reviews Immunology (2005)
CD81 (TAPA-1): A MOLECULE INVOLVED IN SIGNAL TRANSDUCTION AND CELL ADHESION IN THE IMMUNE SYSTEM
Shoshana Levy;Scott C. Todd;Holden T. Maecker.
Annual Review of Immunology (1998)
Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81
Mike Flint;Catherine Maidens;Larry D. Loomis-Price;Christine Shotton.
Journal of Virology (1999)
TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins.
R Oren;S Takahashi;C Doss;R Levy.
Molecular and Cellular Biology (1990)
The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Laura E. Bradbury;Geoffrey S. Kansas;Shoshana Levy;Robert L. Evans.
Journal of Immunology (1992)
Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection.
Susanne Auffermann-Gretzinger;Emmet B. Keeffe;Shoshana Levy.
CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency
Menno C. Van Zelm;Julie Smet;Brigitte Adams;Françoise Mascart.
Journal of Clinical Investigation (2010)
Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants
Alison A. McCormick;Monto H. Kumagai;Kathleen Hanley;Thomas H. Turpen.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
Olivier Silvie;Eric Rubinstein;Jean-François Franetich;Michel Prenant.
Nature Medicine (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: